Agilon Health Sees Q3 Sales $5.775B-$5.860B vs $1.415B Est

Benzinga Newsdesk www.benzinga.com Positive 72.0%

Neg 0% Neu 0% Pos 72%

Agilon Health (NYSE:AGL) sees Q3 sales of $5.775 billion-$5.860 billion vs $1.415 billion analyst estimate.

Comments

No comments yet. Be the first!